Fulcrum Therapeutics' (FULC) FTX-6058 Data is Strong Start, Sets Stage for In-Patient Trial in 4Q21 - Analyst

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. HUBS
3. TRMD
4. SPY
5. AUTO
6. MCD
7. VRTS
8. ABEO
9. MRK
10. NVDA

Go back to Fulcrum Therapeutics' (FULC) FTX-6058 Data is Strong Start, Sets Stage for In-Patient Trial in 4Q21 - Analyst
(NASDAQ: FULC) Delayed: 3.77 --0 (-0%)
Previous Close $3.77    52 Week High $ 
Open $3.77    52 Week Low $ 
Day High $3.77    P/E N/A 
Day Low $3.77    EPS $ 
Volume 3